Literature DB >> 26046815

Type 1 interferons contribute to the clearance of senescent cell.

Yuliya V Katlinskaya1, Christopher J Carbone, Qiujing Yu, Serge Y Fuchs.   

Abstract

The major known function of cytokines that belong to type I interferons (IFN, including IFNα and IFNβ) is to mount the defense against viruses. This function also protects the genetic information of host cells from alterations in the genome elicited by some of these viruses. Furthermore, recent studies demonstrated that IFN also restrict proliferation of damaged cells by inducing cell senescence. Here we investigated the subsequent role of IFN in elimination of the senescent cells. Our studies demonstrate that endogenous IFN produced by already senescent cells contribute to increased expression of the natural killer (NK) receptor ligands, including MIC-A and ULBP2. Furthermore, neutralization of endogenous IFN or genetic ablation of its receptor chain IFNAR1 compromises the recognition of senescent cells and their clearance in vitro and in vivo. We discuss the role of IFN in protecting the multi-cellular host from accumulation of damaged senescent cells and potential significance of this mechanism in human cancers.

Entities:  

Keywords:  DDR, DNA damage response; HGPS, Hutchinson-Gilford progeria syndrome; IFN, type I interferons; IFNAR1, type I IFN receptor; NK cells; NK, natural killer cells; SA-βGal, senescence-associated β-galactosidase; WS, Werner syndrome; interferon; senescence; senescent cell clearance

Mesh:

Substances:

Year:  2015        PMID: 26046815      PMCID: PMC4622626          DOI: 10.1080/15384047.2015.1056419

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  38 in total

Review 1.  Viruses and interferon: a fight for supremacy.

Authors:  Michael G Katze; Yupeng He; Michael Gale
Journal:  Nat Rev Immunol       Date:  2002-09       Impact factor: 53.106

Review 2.  Mechanisms of type-I- and type-II-interferon-mediated signalling.

Authors:  Leonidas C Platanias
Journal:  Nat Rev Immunol       Date:  2005-05       Impact factor: 53.106

3.  DNA damage signaling and p53-dependent senescence after prolonged beta-interferon stimulation.

Authors:  Olga Moiseeva; Frédérick A Mallette; Utpal K Mukhopadhyay; Adrian Moores; Gerardo Ferbeyre
Journal:  Mol Biol Cell       Date:  2006-01-25       Impact factor: 4.138

4.  The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor.

Authors:  Stephan Gasser; Sandra Orsulic; Eric J Brown; David H Raulet
Journal:  Nature       Date:  2005-07-03       Impact factor: 49.962

Review 5.  Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors.

Authors:  Judith Campisi
Journal:  Cell       Date:  2005-02-25       Impact factor: 41.582

6.  Aneuploidy analysis in fibroblasts of human premature aging syndromes by FISH during in vitro cellular aging.

Authors:  A B Mukherjee; C Costello
Journal:  Mech Ageing Dev       Date:  1998-06-15       Impact factor: 5.432

7.  Protein synthetic fidelity in aging human fibroblasts.

Authors:  S Goldstein; R I Wojtyk; C B Harley; J W Pollard; J W Chamberlain; C P Stanners
Journal:  Adv Exp Med Biol       Date:  1985       Impact factor: 2.622

8.  Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence.

Authors:  Akinori Takaoka; Sumio Hayakawa; Hideyuki Yanai; Dagmar Stoiber; Hideo Negishi; Hideaki Kikuchi; Shigeru Sasaki; Kohzoh Imai; Tsukasa Shibue; Kenya Honda; Tadatsugu Taniguchi
Journal:  Nature       Date:  2003-07-31       Impact factor: 49.962

9.  Protein synthetic errors do not increase during aging of cultured human fibroblasts.

Authors:  C B Harley; J W Pollard; J W Chamberlain; C P Stanners; S Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

Review 10.  Hope and fear for interferon: the receptor-centric outlook on the future of interferon therapy.

Authors:  Serge Y Fuchs
Journal:  J Interferon Cytokine Res       Date:  2013-04       Impact factor: 2.607

View more
  7 in total

1.  Type I Interferons Control Proliferation and Function of the Intestinal Epithelium.

Authors:  Yuliya V Katlinskaya; Kanstantsin V Katlinski; Audrey Lasri; Ning Li; Daniel P Beiting; Amy C Durham; Ting Yang; Eli Pikarsky; Christopher J Lengner; F Brad Johnson; Yinon Ben-Neriah; Serge Y Fuchs
Journal:  Mol Cell Biol       Date:  2016-01-25       Impact factor: 4.272

Review 2.  Induction of T Cell Senescence by Cytokine Induced Bystander Activation.

Authors:  Attiya A Abbas; Arne N Akbar
Journal:  Front Aging       Date:  2021-07-09

Review 3.  Recent insights into the cellular and molecular determinants of aging.

Authors:  Linhao Ruan; Xi Zhang; Rong Li
Journal:  J Cell Sci       Date:  2018-02-02       Impact factor: 5.235

4.  NKG2D ligands mediate immunosurveillance of senescent cells.

Authors:  Adi Sagiv; Dominick G A Burton; Zhana Moshayev; Ezra Vadai; Felix Wensveen; Shifra Ben-Dor; Ofra Golani; Bojan Polic; Valery Krizhanovsky
Journal:  Aging (Albany NY)       Date:  2016-02       Impact factor: 5.682

Review 5.  Type I Interferons and Natural Killer Cell Regulation in Cancer.

Authors:  Lena Müller; Petra Aigner; Dagmar Stoiber
Journal:  Front Immunol       Date:  2017-03-31       Impact factor: 7.561

Review 6.  Molecular Mechanisms of Senescence and Implications for the Treatment of Myeloid Malignancies.

Authors:  Philipp Ernst; Florian H Heidel
Journal:  Cancers (Basel)       Date:  2021-02-04       Impact factor: 6.639

7.  Triggering Receptor Expressed on Myeloid Cell 2 R47H Exacerbates Immune Response in Alzheimer's Disease Brain.

Authors:  Olena Korvatska; Kostantin Kiianitsa; Alexander Ratushny; Mark Matsushita; Neal Beeman; Wei-Ming Chien; Jun-Ichi Satoh; Michael O Dorschner; C Dirk Keene; Theo K Bammler; Thomas D Bird; Wendy H Raskind
Journal:  Front Immunol       Date:  2020-09-25       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.